Papers/PMID:41872438
Association of thiamine supplementation with 30-day mortality among ICU patients with sepsis-associated delirium.
Scientific reports2026The record
1 finding · 1 compound · 1 endpoint
What it reported
How to read these marksWhat moved
1 finding
thiamine — decreases all-cause mortality
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Findingreplicated ×2“In crude analysis, thiamine use was associated with a lower risk of 30-day mortality.”
Quoted verbatim from Association of thiamine supplementation with 30-day mortality among ICU patients with sepsis-associated delirium.. - Study
- cohort
- Duration
- 4 weeks
- Population
- Adult ICU patients with sepsis-associated delirium (Sepsis-3, MIMIC-IV, liver disease excluded); 332 received thiamine, 956 did not; crude unadjusted analysis, 30-day follow-up
Association of thiamine supplementation with 30-day mortality among ICU patients with sepsis-associated delirium.2026PMID:41872438Permalink